- THIS ARTICLE
-
Abstract
- Full Text (PDF)
- Alert me when this article is cited
- Alert me if a correction is posted
- SERVICES
- Similar articles in this journal
- Similar articles in PubMed
- Alert me to new issues of the journal
- Download to citation manager
- Reprints & Permissions
- CITING ARTICLES
- Citing Articles via HighWire
- Citing Articles via Google Scholar
- GOOGLE SCHOLAR
- Articles by Lee, L. A.
- Articles by Orr-Weaver, T. L.
- Search for Related Content
- PUBMED
- PubMed Citation
- Articles by Lee, L. A.
- Articles by Orr-Weaver, T. L.
A Genetic Screen for Suppressors and Enhancers of the Drosophila PAN GU Cell Cycle Kinase Identifies Cyclin B as a Target
Laura A. Lee1,a, Lisa K. Elfring1,2,a, Giovanni Boscoa, and Terry L. Orr-Weavera,ba Whitehead Institute, Massachusetts Institute of Technology, Cambridge, Massachusetts 02142
b Department of Biology, Massachusetts Institute of Technology, Cambridge, Massachusetts 02142
Corresponding author: Terry L. Orr-Weaver, Whitehead Institute, 9 Cambridge Ctr., Cambridge, MA 02142., weaver{at}wi.mit.edu (E-mail)
Communicating editor: R. S. HAWLEY
| ABSTRACT |
|---|
The early cell cycles of Drosophila embryogenesis involve rapid oscillations between S phase and mitosis. These unique S-M cycles are driven by maternal stockpiles of components necessary for DNA replication and mitosis. Three genes, pan gu (png), plutonium (plu), and giant nuclei (gnu) are required to control the cell cycle specifically at the onset of Drosophila development by inhibiting DNA replication and promoting mitosis. PNG is a protein kinase that is in a complex with PLU. We employed a sensitized png mutant phenotype to screen for genes that when reduced in dosage would dominantly suppress or enhance png. We screened deficiencies covering over 50% of the autosomes and identified both enhancers and suppressors. Mutations in eIF-5A and PP1 87B dominantly suppress png. Cyclin B was shown to be a key PNG target. Mutations in cyclin B dominantly enhance png, whereas png is suppressed by cyclin B overexpression. Suppression occurs via restoration of Cyclin B protein levels that are decreased in png mutants. The plu and gnu phenotypes are also suppressed by cyclin B overexpression. These studies demonstrate that a crucial function of PNG in controlling the cell cycle is to permit the accumulation of adequate levels of Cyclin B protein.
DROSOPHILA, like many organisms that require rapid embryogenesis in order for their young to reach a motile stage, utilizes a streamlined cell cycle for its early embryonic divisions. The first 13 division cycles occur without cell growth; they are controlled by maternally deposited components and thus are independent of transcription (![]()
Although many cell cycle proteins used during the archetypal G1-S-G2-M cycle also function during the S-M cycles, their regulation must be modified, because they are not regulated transcriptionally during the S-M cycles. The entry into S phase and M phase is controlled by cyclin-dependent kinases (CDKs), a complex of a CDK subunit and a cyclin (for review see ![]()
![]()
![]()
![]()
![]()
![]()
During the embryonic S-M cycles, CDK2/Cyclin E, Cdc2/Cyclin B, Cdc2/Cyclin B3, and Cdc2/Cyclin A complexes are present and have kinase activity, but the high levels of maternal transcripts do not appear to fluctuate (![]()
![]()
![]()
![]()
![]()
![]()
![]()
Another critical cell cycle decision point is exit from mitosis, which is initiated at the metaphase/anaphase transition and requires the degradation of mitotic cyclins (for review see ![]()
![]()
![]()
![]()
![]()
These unique aspects of cell cycle regulation predict that specialized cell cycle regulators might be employed specifically for the S-M cycles. Indeed, the pan gu (png), plutonium (plu), and giant nuclei (gnu) mutations affect the cell cycle solely at the onset of development (![]()
![]()
![]()
![]()
![]()
![]()
Genes that regulate the same biological process can be identified via genetic enhancement and suppression screens. Although screening for recessive mutations that genetically interact is labor intensive, it is possible to obtain dominant enhancement or suppression of a mutant phenotype by reducing the level of another protein that participates in the same process. This can be achieved by decreasing the dosage of a gene via a deletion or a null mutation or by reducing levels of gene transcript (for example, by a P-element insertion into regulatory regions of the gene). Recovery of dominant suppressors or enhancers is facilitated by screening with a sensitized mutant phenotype near a threshold such that changes in severity can be detected (![]()
We undertook a dominant enhancer/suppressor screen in order to identify genes that interact with png to control the S-M cycles. Weak png mutations permit several transient S-M cycles to occur, producing embryos with a characteristic phenotype of multiple polyploid nuclei (![]()
![]()
![]()
We screened a collection of deficiencies and identified suppressors and enhancers of png. In addition, we used this approach to test known cell cycle regulators for interactions with png. These experiments demonstrated that Cyclin B is a key target of PNG.
| MATERIALS AND METHODS |
|---|
Drosophila stocks:
Crosses were carried out at 25° using standard techniques unless otherwise noted (![]()
![]()
![]()
![]()
![]()
![]()
![]()
![]()
![]()
![]()
![]()
Deficiency screen:
The strategy used for the screen to identify deficiencies that dominantly modify png is outlined in Fig 1. The P[w+] transgenes used in this scheme to identify the autosomes carrying deficiencies originated from a cosmid walk performed in this laboratory during the cloning of the ord gene (![]()
|
Chromosomal arm 2L: Df(2L)net-PMF; Df(2L)al; Df(2L)ast2; Df(2L)dp-79b; Df(2L)C144; Df(2L)JS32; Df(2L)cl-h3; Df(2L)E110; Df(2L)spd; Df(2L)30A-C; Df(2L)Prl; Df(2L)esc10; Df(2L)b87e25; Df(2L)osp29; Df(2L)r10; Df(2L)H20; Df(2L)TW137; Df(2L)TW50; Df(2L)pr76; Df(2L)E55; Df(2L)TW84.
Chromosomal arm 2R: Df(2R)M41A4; In(2R)bwVDe2L; Df(2R)nap1; Df(2R)nap9; Df(2R)cn88b; Df(2R)pk78s; Df(2R)cn9; Df(2R)H3C1; Df(2R)44CE; Df(2R)H3E1; Df(2R)B5; Df(2R)X1; Df(2R)GJ68-36; Df(2R)en-B; Df(2R)en30; Df(2R)vg135; Df(2R)vg-C; Df(2R)CX1; Df(2R)vg-B; Df(2R)vg56; Df(2R)trix; Df(2R)Jp1; Df(2R)Jp8; Df(2R)l13; Df(2R)Pcl7B; Df(2R)PC4; Df(2R)Pcl11B; Df(2R)P34; Df(2R)173; Df(2R)AA21, In(2R)AA21; Df(2R)Pu-D17; Df(2R)X58-7; Df(2R)X58-12; Df(2R)59AB; Df(2R)59AD; In(2LR)Px4; Df(2R)Px2; Df(2R)M60E.
Chromosomal arm 3L: Df(3L)emc-E12; Df(3L)emc5; Df(3L)R-G5; Df(3L)R-G7; Df(3L)HR119; Df(3L)GN50; Df(3L)GN24; Df(3L)66C-G28; Df(3L)h-i22; Df(3L)29A6; Df(3L)vin7; Df(3L)Ly; Df(3L)fz-GF3b; Df(3L)fz-M21; Df(3L)BK10; Df(3L)brm11; Df(3L)st-f13; Df(3L)81K19; Df(3L)W10; Df(3L)Cat; Df(3L)W4; Df(3L)VW3; Df(3L)ri-79C.
Chromosomal arm 3R: Dp(3;1)2-2, Df(3R)2-2; Df(3R)Tp110; Df(3R)Scr; Df(3R)p712; Df(3R)p-XT103; Df(3R)ry615; Df(3R)C4; Df(3R)P14; Df(3R)Cha7; Df(3R)Dl-BX12; Df(3R)e-N19; Df(3R)e-R1; Df(3R)e-BS2; Df(3R)crb87-4; Df(3R)crb87-5; Df(3R)XS, Dp(3;3)XS; Df(3R)3450; Df(3R)L127; Df(3R)awd-KRB.
Embryo fixation, staining, and microscopy:
Embryos were collected, dechorionated, fixed, 4',6-diamidino-2-phenylindole (DAPI)-stained, and prepared for microscopy as described by ![]()
![]()
Construction and germline expression of UASp-D46cycB:
The plasmid p-sE-hsp-D46cycB (![]()
![]()
![]()
![]()
|
|
Heat-shock protocol:
For Cyclin A and Cyclin B overexpression experiments summarized in Table 2, hs-cycA and hs-cycB transgenes (![]()
Embryo extracts and immunoblots:
Preparation of embryonic protein extracts and immunoblotting was performed as described in ![]()
![]()
-tubulin using rat anti-
-tubulin (YL1/2, Harlan Sera-lab, 1:200).
| RESULTS |
|---|
Identification of deficiencies that suppress or enhance png mutations:
We initiated a screen to identify mutants that enhance or suppress weak png mutations by using the deficiency collection available from the Bloomington Stock Center to survey about 50% of the genome using a minimum number of stocks and crosses. We scored for deficiencies that when heterozygous would dominantly suppress or enhance weak png mutations by examining the nuclear phenotype of embryos. Females transheterozygous for the weak png3318 allele and the strong png1058 allele produce embryos in which some mitotic divisions occur before the nuclei ultimately become polyploid. These embryos contain up to 16 giant, polyploid nuclei (Fig 2A and Fig 3A). In the same collections, there are embryos that have a single, multilobed nucleus that results from the female meiotic products and male pronucleus undergoing DNA replication but no nuclear division. As these nuclei become polyploid they can fuse together. Thus, in the absence of mitosis and nuclear division, between one and five giant polyploid nuclei are produced. We scored these two classes of embryos as those with five or fewer nuclei vs. those with greater than five (multinucleated). The relative percentages of these two classes produced by png3318/png1058 females is affected by genetic background and can vary between 30 and 55%. Thus we defined suppression as genotypes producing >60% multinucleated embryos and enhancement as <30%.
|
|
Embryos were collected for 04 hr from y png3318 w/y png1058 w females carrying a deficiency on the second or third chromosome. The embryos were fixed and stained with DAPI. The females with the deficiency were distinguished from their sibling controls by the absence of a dominant P[w+] marker carried on the autosome (Fig 1). Enhancement of the png mutant phenotype was evident by a reduction in the number of embryos with greater than five nuclei (Fig 2B). Suppression was identified by the appearance of an increased number of embryos with multiple nuclei; strong suppressors also produced some embryos that had a greater number of nuclei than the maximum of 16 typically seen in embryos from png3318/png1058 females (Fig 2C). Some of the deficiencies that were identified as suppressors were subsequently tested for their ability to suppress females homozygous for the strong allele, png1058/png1058, to produce embryos with multiple nuclei (Table 1).
We screened 59 deficiency intervals on the second chromosome and 42 intervals on the third chromosome. These deficiencies spanned
62% of the second and
47% of the third chromosome. As a control that the screen was effective we recovered a deficiency for plu (Df(2R)173) as an enhancer of the png phenotype. We identified 8 deficiencies that strongly enhance the png phenotype, 12 that weakly enhance, and 8 that suppress png mutations (Table 1).
To identify the locus within each deficiency responsible for the genetic interaction with png, we tested lethal P-element insertions within or adjacent to each interval for interaction with png and, when possible, examined deficiencies that dissect the interval. This screen led to the identification of five single complementation groups that interact genetically with png. The strongest enhancer we identified was cyclin B, discussed in detail below. The strongest suppressors were eIF-5A and PP1 87B, described below. Two weaker enhancers were recovered: l(2)s4989 is a P-element insertion that disrupts a novel gene and l(2)10481 is a P-element insertion 5' to the Tkr gene (Tyrosine kinase-related).
Cyclin B is a target of png:
Two deficiencies that remove the 59AB region on chromosome 2R strongly enhanced the png mutant phenotype (Table 1; compare Fig 2B and A). This region contains the cyclin B gene (![]()
![]()
![]()
Conversely, we wanted to test whether we could suppress the phenotype by increasing the level of Cyclin B protein in the png mutant embryos, so we crossed multiple copies (six to eight) of the wild-type cyclin B gene into the png mutant background. We showed by immunoblotting that strains with extra copies of the cyclin B gene in the png mutant background produced increased amounts of Cyclin B protein (Fig 4). Overexpression of cyclin B strongly suppressed the png mutants. In the weak png3318 mutants with extra copies of the cyclin B gene, there was a striking increase in the number of nuclei in the embryos as well as in the number of embryos with multiple nuclei (Table 2; compare Fig 5C and A). In addition, the polar bodies contained condensed chromosomes with a normal rosette arrangement (compare Fig 5H and Fig G). This extent of suppression was not observed with any other deficiency or mutant tested. Moreover, the chromosomes of the zygotic nuclei were condensed, and mitotic figures were visible (Fig 5E and Fig F). The suppression of the zygotic nuclei was not complete, however, because all of the embryos contained polyploid nuclei (Fig 5C), and none survived past embryogenesis. Thus, the linkage between S and M phases was ultimately broken, and nuclear division ceased. Overexpression of cyclin B dramatically suppressed the strong png1058 mutants as well, resulting in multiple nuclei in these embryos (Table 2; compare Fig 5D and Fig B). However, unlike the weak png3318 mutants with extra cyclin B, normal polar bodies were not observed.
|
|
Cyclin B levels were also increased in png mutants by heat-shock induction and by induction in the germline using GAL4 under the control of the nanos promoter. The cyclin B gene in the latter construct lacks the N-terminal destruction box and thus would promote elevated levels of Cyclin B both from transcriptional induction as well as lack of degradation by the ubiquitin-APC/C pathway (![]()
Increased cyclin B suppresses the plutonium and gnu phenotypes:
Given the observation that png, plu, and gnu appear to function in a common pathway, the genetic interactions between png and cyclin B, and the decreased Cyclin B protein levels in plu and gnu mutants, we wanted to test whether or not the plu and gnu phenotypes could be modified by altering the cyclin B gene dosage. Unlike png, all of the existing mutations in plu and the single gnu mutation appear to be null alleles (![]()
![]()
![]()
![]()
Effects of mutations in other cyclin genes on the png phenotype:
In addition to Cyclin B, the levels of Cyclin A protein are decreased in proportion to the strength of the png allele. Surprisingly, neither a deficiency that uncovers cyclin A nor mutations in the gene enhanced the png mutant phenotype (Table 2 and data not shown). A negative result in this test does not exclude the possibility of interaction because a twofold reduction in gene dosage may not decrease the level of gene product below a threshold required to detect an effect. However, loss of one copy of the cyclin A gene in the mother does affect cell cycle parameters and nuclear division in the embryo (![]()
![]()
![]()
Mutation of the cyclin B3 gene (![]()
![]()
![]()
![]()
The eIF-5A and PP1 87B genes suppress png mutations:
The deficiency Df(2R)Px2 strongly suppresses the png mutant phenotype. To identify the gene responsible for this interaction, we tested available lethal P element insertions both within the genomic interval of this deficiency and in immediately adjacent-lettered divisions. We found that a P-element inserted within the first intron of the eIF-5A gene suppresses png (Table 3; compare Fig 3D and Fig B). The eIF-5A mutation lies in the region of Df(2R)Px2, but it complements the deficiency and thus lies outside of it. Consequently, both eIF-5A and another as yet unidentified locus inside the deficiency are suppressors of png. We confirmed that the eIF-5A mutation is a suppressor by testing an independent P-element insertion in the eIF-5A gene and observing that it also caused suppression (Table 3). The lethal phenotype of these mutations has not been analyzed, and the gene is defined on the basis of its homology to eukaryotic orthologs of the eIF-5A protein. Although the eIF-5A protein was identified by its ability to promote peptide bond formation in vitro, its role in translation and gene expression is not well understood (![]()
|
To test whether the effect of eIF-5A on png could be due to perturbations in translation initiation, we crossed mutations in the translation initiation factors eIF-4a, eIF-4E, and eIF-3p40 into png mutants, but did not observe enhancement or suppression of the phenotype (Table 3). We also examined mutations in two other genes known to be involved in translation, poney and plume (![]()
Reduction of the gene dosage of the type 1 serine/threonine protein phosphatase PP1 87B appears to be responsible for suppression of the png phenotype by Df(3R)ry615 (compare Fig 2C and A). We tested the j6E7 mutation in the PP1 87B gene and found dominant suppression of the png3318/png1058 phenotype with 78% multinucleated embryos compared to 41% in sibling controls. PP1 87B also suppressed females homozygous for the strong allele, png1058, to produce multinucleated embryos (data not shown). This suppression could be direct in that PP1 could be responsible for dephosphorylating the substrates of the PNG kinase. It is possible, however, given the pleiotrophic nature of PP1 87B phenotypes that it is suppressing indirectly (![]()
![]()
![]()
Analysis of candidate cell cycle regulators:
In addition to the deficiency screen, we tested for interactions between png and known cell cycle regulators. The kinase activity of Cdc2 is decreased in png mutant embryos, presumably due to the reduction in Cyclin A and Cyclin B protein levels (![]()
![]()
![]()
![]()
![]()
![]()
![]()
![]()
![]()
![]()
![]()
![]()
![]()
![]()
To test whether png might affect mitotic cyclin levels by controlling cyclin protein degradation, we examined mutations in genes encoding the APC/C regulators fizzy (fzy) and fzy-related (fzr) as well as mutations in an APC/C subunit and many components of the ubiquitination pathway. We found that none of five mutations in fzy tested affected the png phenotype (data not shown; ![]()
![]()
![]()
![]()
![]()
![]()
![]()
![]()
| DISCUSSION |
|---|
The use of a weak allele of png in trans to a strong allele provided a sensitized system that permitted us to screen for genes whose reduced dosage would suppress or enhance the png mutant phenotype. Suppression or enhancement resulting from reduced gene dosage requires less specificity than does an interaction with a missense mutation. In addition, genetic interactions arising from changes in gene dosage are more likely to be dominant. These two features made it feasible to screen for suppressors and enhancers of a phenotype that required collection and staining of embryos for microscopic examination.
We found that a mutation in cyclin B dominantly enhanced png. The addition of extra copies of the wild-type cyclin B gene increased the level of Cyclin B protein in the embryos to near wild-type levels and dramatically suppressed png. Increased Cyclin B suppressed both of the major defects seen in png mutants: inappropriate replication in the polar bodies and the near absence of mitosis in the zygotic nuclei. It is striking that increased Cyclin B also suppressed the plu and gnu mutants such that zygotic nuclei underwent some mitotic divisions. We had never previously observed suppression of the plu phenotype (e.g., by deficiencies or mutations that dominantly suppress png). Although the function of GNU is not known, nor is it known where it acts in the PNG pathway, the suppression by increased copies of cyclin B suggests that it also critically controls Cyclin B levels. Thus, Cyclin B is a key target of both the PNG/PLU complex and GNU.
Suppression of the weak png mutation by increased Cyclin B restored the normal rosette structure and ploidy to the polar bodies. In wild-type embryos, the unused female meiotic products exit the postmeiotic interphase, their chromosomes condense, and these nuclei remain arrested in a metaphase-like state despite sharing the same cytoplasm with dividing nuclei. These observations lead to two conclusions about the regulation of the cell cycle in the polar bodies. First, condensation of the chromosomes is likely to prevent DNA replication and, second, Cyclin B is the sole PNG target necessary for condensation and inhibition of DNA replication in the polar bodies.
The suppression of png, plu, and gnu by overexpressing cyclin B is not complete because ultimately nuclear divisions fail, and the nuclei continue to replicate and become polyploid. It is possible that Cyclin B is the sole target of the PNG/PLU Complex and GNU and that the levels of increased Cyclin B protein in the png, plu, and gnu mutants (via increased copies of the cyclin B gene) are not adequate for completion of all the S-M cycles. However, it seems more likely that, although Cyclin B is a key target, other targets of the PNG/PLU complex and GNU are also important. Cyclin A is a particularly good candidate for two reasons. Cyclin A protein levels are decreased in png, plu, and gnu mutants; for png, the decrease is in proportion to the strength of the allele (![]()
![]()
![]()
We did not observe an enhancement of the png phenotype by mutations in cyclin A, and overexpression of cyclin A unexpectedly enhanced the phenotype. This latter result likely reflects the ability of excess Cyclin A to promote DNA replication (![]()
![]()
There are several mechanisms by which PNG, PLU, and GNU could affect Cyclin A and B protein levels including maternal transcription, mRNA stability or processing, translation, and cyclin protein stability. We examined mutations in the pathway that targets mitotic cyclin proteins for destruction. We did not observe suppression of the png mutant phenotype by reducing the dosage of the two known activators of cyclin destruction, fzy or fzr. Similarly, mutation of an APC/C subunit or several genes affecting the ubiquitin pathway did not alter the png mutant phenotype. These negative results do not exclude a role for PNG in controlling APC/C-mediated protein degradation, as the dosage reductions may not have reduced protein activity below a crucial threshold. Additional experiments will be required to evaluate how PNG affects Cyclin A and B protein levels.
In addition to cyclin A and B, we examined the effects of alterations in the gene dosage of other cyclins on the png phenotype. Embryos from mutant png females appear to have normal Cyclin B3 protein levels by immunoblotting (our unpublished observations), and decreasing the cyclin B3 gene dosage had no effect on the png phenotype. However, addition of eight extra copies of the wild-type cyclin B3 gene resulted in suppression of the weak png phenotype. We considered the possibility that overexpression of cyclin B3 might suppress png by causing an increase in Cyclin B (e.g., via competition for APC/C-mediated protein degradation), but immunoblotting revealed no change in Cyclin B protein levels. The suppression of png by overexpression of cyclin B3 could be a consequence of overlapping functions of Cyclins A, B, and B3 during mitosis (![]()
![]()
Given the well-established role for Cyclin E in progression through S phase, we were surprised to find that decreasing the cyclin E gene dosage enhanced the png phenotype. Consistent with this observation, mutation of dacapo, a CDK2/Cyclin E kinase inhibitor, slightly suppressed png. In addition to promotion of S phase, other cell cycle roles have been ascribed to Cyclin E that might account for the enhancement of png by decreased cyclin E. For example, in Xenopus egg extracts, Cdk2/Cyclin E has been implicated in activation of Cdc2/Cyclin B for progression into mitosis (![]()
![]()
There are two precedents for how Cyclin E could affect DNA replication in a manner that would enhance png. A paradoxical role for Cdk2/Cyclin E as a negative regulator of DNA replication in Xenopus extracts has been described (![]()
![]()
Mutation of eIF-5A strongly suppressed png mutants. We cannot at present distinguish whether this is so because eIF-5A directly influences the same process as png (i.e., Cyclin B protein levels) or whether the suppression results from compensatory changes in the cell cycle. Although we did not detect an increase in Cyclin B protein in png1058/png1058; eIF-5A/+ strains by immunoblotting, it is possible that Cyclin B was increased sufficiently to account for the suppression seen or that its local concentration in the vicinity of the zygotic nuclei was increased.
The difficulty in defining the relationship between eIF-5A and png is in large part due to the fact that the biological function of eIF-5A is not understood, and it is not clear that its primary function is in translation initiation. Consistent with this, we did not observe a genetic interaction between genes that encode known translation initiation proteins or other proteins in the translational machinery. Mutation of eIF-5A in yeast decreases general protein translation by 30% (![]()
![]()
![]()
![]()
An alternative explanation is that mutation of eIF-5A suppresses png mutants as an indirect consequence of eIF-5A's role in promoting the onset of S phase. The activities of eIF-5A in translation initiation in vitro and RNA transport require a unique post-translational modification of the eIF-5A protein, hypusination (![]()
![]()
![]()
![]()
The third interacting gene we recovered from this screen encodes the serine/threonine protein phosphatase PP1 87B. This type 1 phosphatase might dephosphorylate PNG substrates, such that reducing the activity of the phosphatase suppresses png mutations. The suppression could be indirect, however. Mutations in PP1 87B cause a mitotic arrest with predicted high levels of mitotic cyclin proteins, which could alleviate the png phenotype (![]()
![]()
![]()
![]()
This genetic screen led to the important identification of Cyclin B as a PNG target. In addition, an unanticipated interaction between png and eIF-5A was uncovered. Identification of the genes responsible for the suppression or enhancement observed with the other deficiencies will provide key insights into the mechanism by which the PNG/PLU protein kinase complex controls the S-M cell cycles.
| FOOTNOTES |
|---|
1 These authors contributed equally to this work. ![]()
2 Present address: Department of Biochemistry, 1041 E. Lowell St., University of Arizona, Tucson, AZ 85721. ![]()
| ACKNOWLEDGMENTS |
|---|
We acknowledge technical assistance on the screen provided by Doug Van Hoewyk and Colleen Raymond. We are grateful to the Bloomington Stock Center for providing the deficiency kit and mutant strains. We thank Christian Lehner for the cyclin A, B, and B3 overexpression strains as well as cyclin B and cyclin B3 mutant strains; Pat O'Farrell for Cyclin B antibodies and the D46 cyclin B cDNA; Pernille Rorth for the UASp vector and nanos-Gal4: VP16 transgenic line; and Amy Beaton (BDGP) for the eIF-5A allele l(2)10530. We benefited from helpful discussions with Doug Fenger, Tom Dever, and Steve Elledge. Confocal microscopy was done in the Keck Imaging Center at the Whitehead Institute. L.A.L. was supported by a postdoctoral fellowship from the National Institutes of Health (NIH), L.K.E. was supported by a postdoctoral fellowship from the American Cancer Society, and G.B. is a postdoctoral fellow of the Damon Runyon-Walter Winchell Cancer Research Fund (DRG 1537) and a Margaret and Herman Sokol Fellow of the Whitehead Institute. This work was supported by NIH grant GM39341 to T.O.-W.
Manuscript received November 21, 2000; Accepted for publication May 7, 2001.
| LITERATURE CITED |
|---|
ASHBURNER, M., S. MISRA, J. ROOTE, S. E. LEWIS, and R. BLAZEJ et al., 1999 An exploration of the sequence of a 2.9-Mb region of the genome of Drosophila melanogaster. The Adh region. Genetics 153:179-219
AXTON, J. M., V. DOMBRADI, P. T. W. COHEN, and D. M. GLOVER, 1990 One of the protein phosphatase 1 isoenzymes in Drosophila is essential for mitosis. Cell 63:33-46[Medline].
AXTON, J. M., F. L. SHAMANSKI, L. M. YOUNG, D. S. HENDERSON, and J. B. BOYD et al., 1994 The inhibitor of DNA replication encoded by the Drosophila gene plutonium is a small, ankyrin repeat protein. EMBO J. 13:462-470[Medline].
BAKSA, K., H. MORAWIETZ, V. DOMBRADI, M. AXTON, and H. TAUBERT et al., 1993 Mutations in the protein phosphatase 1 gene at 87B can differentially affect suppression of position-effect variegation and mitosis in Drosophila melanogaster.. Genetics 135:117-125[Abstract].
BICKEL, S. E., D. W. WYMAN, W. Y. MIYAZAKI, D. P. MOORE, and T. L. ORR-WEAVER, 1996 Identification of ORD, a Drosophila protein essential for sister-chromatid cohesion. EMBO J. 15:1451-1459[Medline].
CASTRILLON, D. H., P. GONCZY, S. ALEXANDER, R. RAWSON, and C. G. EBERHART et al., 1993 Toward a molecular genetic analysis of spermatogenesis in Drosophila melanogaster: characterization of male-sterile mutants generated by single P element mutagenesis. Genetics 135:489-505[Abstract].
CENCI, G., R. B. RAWSON, G. BELLONI, D. H. CASTRILLON, and M. TUDOR et al., 1997 UbcD1, a Drosophila ubiquitin-conjugating enzyme required for proper telomere behavior. Genes Dev. 11:863-875
D'ANDREA, R. J., R. STRATMANN, C. F. LEHNER, U. P. JOHN, and R. SAINT, 1993 The three rows gene of Drosophila melanogaster encodes a novel protein that is required for chromosome disjunction during mitosis. Mol. Biol. Cell 4:1161-1174[Abstract].
DAWSON, I. A., S. ROTH, M. AKAM, and S. ARTAVANIS-TSAKONAS, 1993 Mutations at the fizzy locus cause metaphase arrest in Drosophila melanogaster embryos. Development 117:359-376[Abstract].
DAWSON, I. A., S. ROTH, and S. ARTAVANIS-TSAKONAS, 1995 The Drosophila cell cycle gene fizzy is required for normal degradation of cyclins A and B during mitosis and has homology to the CDC20 gene of Saccharomyces cerevisiae.. J. Cell Biol. 129:725-737
DE NOOIJ, J. C., M. A. LETENDRE, and I. K. HARIHARAN, 1996 A cyclin-dependent kinase inhibitor, Dacapo, is necessary for timely exit from the cell cycle during Drosophila embryogenesis. Cell 87:1237-1247[Medline].
DONG, X., K. H. ZAVITZ, B. J. THOMAS, M. LIN, and S. CAMPBELL et al., 1997 Control of G1 in the developing Drosophila eye: rca1 regulates Cyclin A. Genes Dev. 11:94-105
DURONIO, R. J., P. H. O'FARRELL, J.-E. XIE, A. BROOK, and N. DYSON, 1995 The transcription factor E2F is required for S phase during Drosophila embryogenesis. Genes Dev. 9:1445-1455
EDGAR, B. A., F. SPRENGER, R. J. DURONIO, P. LEOPOLD, and P. H. O'FARRELL, 1994 Distinct molecular mechanisms regulate cell cycle timing at successive stages of Drosophila embryogenesis. Genes Dev. 8:440-452
EDWARDS, M. C., N. LIEGEOIS, J. HORECKA, R. A. DE PINHO, and G. F. SPRAGUE et al., 1997 Human CPR (cell cycle progression restoration) genes impart a Far-phenotype on yeast cells. Genetics 147:1063-1076[Abstract].
FENGER, D. D., J. L. CARMINATI, D. L. BURNEY-SIGMAN, H. KASHEVSKY, and J. L. DINES et al., 2000 PAN GU: a protein kinase that inhibits S phase and promotes mitosis in early Drosophila development. Development 127:4763-4774[Abstract].
FINLEY, R. L., B. J. THOMAS, S. L. ZIPURSKY, and R. BRENT, 1996 Isolation of Drosophila cyclin D, a protein expressed in the morphogenetic furrow before entry into S phase. Proc. Natl. Acad. Sci. USA 93:3011-3015
FOE, V. E., G. M. ODELL and B. A. EDGAR, 1993 Mitosis and morphogenesis in the Drosophila embryo: point and counterpoint, pp. 149300 in The Development of Drosophila melanogaster, edited by M. BATE and A. MARTINEZ ARIAS. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY.
FOGARTY, P., S. CAMPBELL, R. ABU-SHUMAYS, B. PHALLE, and K. YU et al., 1997 The Drosophila grapes gene is related to checkpoint gene chk1/rad27 and is required for late syncytial division fidelity. Curr. Biol. 7:418-426[Medline].
FREEMAN, M. and D. GLOVER, 1987 The gnu mutation of Drosophila causes inappropriate DNA synthesis in unfertilized and fertilized eggs. Genes Dev. 1:924-930.
FREEMAN, M., C. NUSSLEIN-VOLHARD, and D. GLOVER, 1986 The dissociation of nuclear and centrosomal division in gnu, a mutation causing giant nuclei in Drosophila. Cell 46:457-468[Medline].
GALLONI, M. and B. A. EDGAR, 1999 Cell-autonomous and non-autonomous growth-defective mutants of Drosophila melanogaster. Development 126:2365-2375[Abstract].
GLOTZER, M., A. W. MURRAY, and M. W. KIRSCHNER, 1991 Cyclin is degraded by the ubiquitin pathway. Nature 349:132-138[Medline].
GREENSPAN, R. J., 1997 Fly Pushing: The Theory and Practice of Drosophila Genetics. Cold Spring Harbor Laboratory Press, Plainview, NY.
GUADAGNO, T. M. and J. W. NEWPORT, 1996 Cdk2 kinase is required for entry into mitosis as a positive regulator of Cdc2-cyclin B kinase activity. Cell 84:73-82[Medline].
HANAUSKE-ABEL, H. M., M. H. PARK, A. R. HANAUSKE, A. M. POPOWICZ, and M. LALANDE et al., 1994 Inhibition of the G1-S transition of the cell cycle by inhibitors of deoxyhypusine hydroxylation. Biochim. Biophys. Acta 1221:115-124[Medline].
HANAUSKE-ABEL, H. M., B. SLOWINSKA, S. ZAGULSKA, R. C. WILSON, and L. STAIANO-COICO et al., 1995 Detection of a sub-set of polysomal mRNAs associated with modulation of hypusine formation at the G1-S boundary. Proposal of a role for eIF-5A in onset of DNA replication. FEBS Lett. 366:92-98[Medline].
HAYASHI, S., S. HIROSE, T. METCALFE, and A. D. SHIRRAS, 1993 Control of imaginal cell development by the escargot gene of Drosophila.. Development 118:105-115[Abstract].
HUA, X. H., H. YAN, and J. NEWPORT, 1997 A role for Cdk2 kinase in negatively regulating DNA replication during S phase of the cell cycle. J. Cell Biol. 137:183-192
HUANG, J. and J. W. RAFF, 1999 The disappearance of cyclin B at the end of mitosis is regulated spatially in Drosophila cells. EMBO J. 18:2184-2195[Medline].
JACOBS, H., J. KNOBLICH, and C. LEHNER, 1998 Drosophila Cyclin B3 is required for female fertility and is dispensable for mitosis like Cyclin B. Genes Dev. 12:3741-3751
KANG, A. H. and J. W. B. HERSHEY, 1994 Effect of initiation factor eIF-5A depletion on protein synthesis and proliferation of Saccharomyces cerevisiae.. J. Biol. Chem. 269:3934-3940




